In late 2024, Illumina and NVIDIA forged a powerhouse alliance, blending Illumina’s genomic sequencing with NVIDIA’s AI wizardry to accelerate multiomic data analysis. Unveiled at the J.P. Morgan Healthcare Conference, this partnership aims to streamline drug discovery and empower pharma with cutting-edge tools. Despite grappling with new U.S. AI chip export rules, NVIDIA remains optimistic. With collaborators like Mayo Clinic and IQVIA on board, the $10T healthcare sector could see some byte-sized breakthroughs!